Australia markets close in 30 minutes

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
23.69-1.28 (-5.14%)
At close: 04:00PM EDT
23.69 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
210,762
210,762
142,760
121,308
45,200
Selling general and administrative
31,400
31,400
28,202
28,717
13,447
Total operating expenses
242,162
242,162
170,962
150,025
58,647
Operating income or loss
-242,162
-242,162
-170,962
-150,025
-58,647
Interest expense
-
-
-
0
396
Total other income/expenses net
-1,416
-1,416
-54
-8
-450
Income before tax
-235,937
-235,937
-168,099
-149,291
-59,437
Income from continuing operations
-235,937
-235,937
-168,099
-149,291
-59,437
Net income
-235,937
-235,937
-168,099
-149,291
-59,437
Net income available to common shareholders
-235,937
-235,937
-168,099
-149,291
-59,437
Basic EPS
-3.59
-
-3.23
-2.93
-4.13
Diluted EPS
-3.59
-
-3.23
-2.93
-4.13
Basic average shares
57,538
-
51,976
50,895
14,396
Diluted average shares
57,538
-
51,976
50,895
14,396